<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Applied Information Aspects of Medicine (Prikladnye informacionnye aspekty mediciny)</journal-id><journal-title-group><journal-title>Applied Information Aspects of Medicine (Prikladnye informacionnye aspekty mediciny)</journal-title></journal-title-group><issn publication-format="electronic">2070-9277</issn><publisher><publisher-name>Voronezh State Medical University named after N.N. Burdenko - The State Budgetary Institution of Higher Professional Education «Voronezh State Medical University named after N.N. Burdenko» of the Ministry of Public Health of the Russian</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1871</article-id><article-id pub-id-type="doi">10.18499/2070-9277-2016-19-1-92-98</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>BASIC PRINCIPLES OF TREATMENT OF ANTIPHOSPHOLIPID SYNDROME</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kutashov</surname><given-names>V A</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ulyanova</surname><given-names>O V</given-names></name><bio></bio><email>alatau08@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Voronezh State Medical University</aff><pub-date date-type="epub" iso-8601-date="2016-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2016</year></pub-date><volume>19</volume><issue>1</issue><fpage>92</fpage><lpage>98</lpage><history><pub-date date-type="received" iso-8601-date="2020-04-24"><day>24</day><month>04</month><year>2020</year></pub-date></history><permissions><copyright-statement>Copyright © 2016, Прикладные информационные аспекты медицины</copyright-statement><copyright-year>2016</copyright-year></permissions><abstract>Antiphospholipid syndrome (APS) refers to date one of the most urgent problems of modern medicine multidisciplinary. Due to the variety of clinical manifestations of APS is a sphere of interest of clinicians of different specialties - rheumatologists, cardiologists, obstetricians, hematologists, pediatricians. Of particular interest APS makes neurologists as the most frequent manifestations of the disease are ischemic cerebrovascular disorder (CVD). Less common are seizures, dementia, headache, chorea, peripheral neuropathy, encephalopathy, and myeloma, simulating multiple sclerosis syndrome. Since the APS has the variety of clinical manifestations, up-to-date, the question remains as to the treatment of APS, and on preventive measures.</abstract><kwd-group xml:lang="ru"><kwd>антифосфолипидный синдром</kwd><kwd>нарушения мозгового кровообращения</kwd><kwd>профилактика</kwd><kwd>лечение</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Бадокин В.В. Ревматология. Клинические лекции / В.В. Бадокин - М.:Литтерра,2014. - 592с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Калашникова Л.А. Неврология антифосфолипидного синдрома. / Л.А. Калашникова - М.: Медицина, 2003. - 256 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Калашникова Л.А. Неишемические неврологические проявления у больных с первичным антифосфолпидным синдромом (опыт собственных 16-летних исследований). / Л.А. Калашникова // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2005. - №105(2). - С. - 18 - 23.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Насонов Е.Л. Антифосфолипидный синдром./ Е.Л. Насонов- М., 2004. - 440 с.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Неврологические проявления у больных с антифосфолипидным синдромом: учебно-методические рекомендации для врачей неврологов, нейрохирургов, травматологов, терапевтов, врачей общей практики, клинических ординаторов и интернов / В.А. Куташов, А.В. Чернов, О.В. Ульянова, Л.А. Куташова. - Воронеж: ВГМУ, 2016. - 92с.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>The antiphospholipid syndrome: history, definition, classification, and differential diagnosis // The Antiphospholipid Syndrome / Eds R. A. Asherson [et al.] - Boca Raton, 1996. - P. 3- 12.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind,placebo-controlled trial in asymptomatic antiphospholipid antibodypositive individuals / Erkan D [et al.] // Arthritis Rheum - 2007 - Vol. 56. - Р. 2382 - 2391.</mixed-citation></ref></ref-list></back></article>
